Copyright © Inderes 2011 - present. All rights reserved.

Spago Nanomedical

0.22

 

SEK

 

+6.8 %

SPAGO

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Be the first to follow this company
Compare
+6.8%
+12.24%
+25%
-5.98%
-24.66%
-35.67%
-95.14%
-98.36%
-98.07%

Spago Nanomedical conducts research and development in cancer diagnostics. The company conducts various development projects based on its proprietary nanomaterials whose potential is found in making tumours visible, and enabling internal radiation therapy of cancer. The company was founded in 2007 and is based in Lund.

Read more
Market cap
76.6M SEK
Turnover
38.7K SEK
Revenue
1.2M
EBIT %
-3,589.17 %
P/E
-
Dividend yield-%
-
Financial calendar
6.2
2025

Annual report '24

7.5
2025

Interim report Q1'25

20.8
2025

Interim report Q2'25

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.